Cetuximab selectively binds to EGFR and competitively inhibits the binding of EGF and other ligands, preventing its activation, eventually inhibiting the growth of cancer cells and production of MMP and EGF and inducing apoptosis [45]. Here, EGFR is linked to cancer.